Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trialHugues Chabriat, Usman Khan, Aurore Sors et al.|The Lancet Neurology|2020Cited by 51
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countriesCelso Arango, Jannie van der Westhuizen, Jan K. Buitelaar et al.|The Lancet Psychiatry|2021Cited by 33